Literature DB >> 30395944

Mechanistic insights into m6A RNA enzymes.

Tina Lence1, Chiara Paolantoni1, Lina Worpenberg1, Jean-Yves Roignant2.   

Abstract

The field of RNA modifications, so-called epitranscriptomics, has flourished over the past years owing to improvements of detection methods and the identification of important regulatory players. N6-methyladenosine (m6A) is the most abundant internal modification in messenger (mRNA) and long non-coding (lncRNA), and controls most steps of RNA metabolism. Its physiological roles range from gametogenesis, stem cell differentiation to immunity, neuronal development and functions, while its alterations are associated with cancer development and progression. In this review we focus on the proteins that catalyze formation of m6A (also called writers) on RNA. Interestingly, distinct proteins deposit m6A on different classes of RNA, indicating that specific RNA features dictate recognition mechanisms. Associated factors and post-translational modifications can also alter m6A enzyme activity. A better understanding of the underlying regulation involved in m6A deposition is the first step towards developing tools for cancer therapy and for treatment of other m6A-associated diseases.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  MAC; MACOM; Mettl16; Mettl3; RNA modifications; RlmJ; m(6)A

Mesh:

Substances:

Year:  2018        PMID: 30395944     DOI: 10.1016/j.bbagrm.2018.10.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  31 in total

Review 1.  Small changes, big implications: The impact of m6A RNA methylation on gene expression in pluripotency and development.

Authors:  Adam M Heck; Carol J Wilusz
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-17       Impact factor: 4.490

2.  m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation.

Authors:  Jie Li; Lijun Zhu; Yanhong Shi; Jingnan Liu; Lin Lin; Xi Chen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  The 18S ribosomal RNA m6 A methyltransferase Mettl5 is required for normal walking behavior in Drosophila.

Authors:  Jessica Leismann; Mariangela Spagnuolo; Mihika Pradhan; Ludivine Wacheul; Minh Anh Vu; Michael Musheev; Pablo Mier; Miguel A Andrade-Navarro; Marc Graille; Christof Niehrs; Denis Lj Lafontaine; Jean-Yves Roignant
Journal:  EMBO Rep       Date:  2020-04-29       Impact factor: 8.807

4.  Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors.

Authors:  Simona Selberg; Neinar Seli; Esko Kankuri; Mati Karelson
Journal:  ACS Omega       Date:  2021-05-14

Review 5.  Role of m6A in osteoporosis, arthritis and osteosarcoma (Review).

Authors:  Yibo Hu; Xiaohui Zhao
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

6.  m6A RNA Immunoprecipitation Followed by High-Throughput Sequencing to Map N6-Methyladenosine.

Authors:  Devi Prasad Bhattarai; Francesca Aguilo
Journal:  Methods Mol Biol       Date:  2022

Review 7.  The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics?

Authors:  Matthias R Schaefer
Journal:  Genes (Basel)       Date:  2021-02-26       Impact factor: 4.096

Review 8.  A mark of disease: how mRNA modifications shape genetic and acquired pathologies.

Authors:  Eliana Destefanis; Gülben Avşar; Paula Groza; Antonia Romitelli; Serena Torrini; Pınar Pir; Silvestro G Conticello; Francesca Aguilo; Erik Dassi
Journal:  RNA       Date:  2020-12-29       Impact factor: 4.942

Review 9.  Regulatory Mechanisms of the RNA Modification m6A and Significance in Brain Function in Health and Disease.

Authors:  Justine Mathoux; David C Henshall; Gary P Brennan
Journal:  Front Cell Neurosci       Date:  2021-05-19       Impact factor: 5.505

Review 10.  The Role of N6 -Methyladenosine Modified Circular RNA in Pathophysiological Processes.

Authors:  Mei Tang; Yonggang Lv
Journal:  Int J Biol Sci       Date:  2021-06-01       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.